BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dhermain F. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches. Chin J Cancer 2014;33:16-24. [PMID: 24384237 DOI: 10.5732/cjc.013.10217] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Ma H, Wang Z, Hu L, Zhang S, Zhao C, Yang H, Wang H, Fang Z, Wu L, Chen X. The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas. Biochem Biophys Res Commun 2018;496:1322-30. [PMID: 29408377 DOI: 10.1016/j.bbrc.2018.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Verger A, Langen K; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, France, IADI, INSERM, UMR 947, Lorraine University, Nancy, France, Department of Nuclear Medicine, University of Aachen, Aachen, Germany, Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany. PET Imaging in Glioblastoma: Use in Clinical Practice. In: De Vleeschouwer S, editor. Glioblastoma. Codon Publications; 2017. pp. 155-74. [DOI: 10.15586/codon.glioblastoma.2017.ch9] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
3 Guo L, Wang G, Feng Y, Yu T, Guo Y, Bai X, Ye Z. Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors. Radiat Oncol 2016;11:123. [PMID: 27655356 DOI: 10.1186/s13014-016-0702-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
4 Mirimanoff RO. High-grade gliomas: reality and hopes. Chin J Cancer 2014;33:1-3. [PMID: 24384235 DOI: 10.5732/cjc.013.10215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
5 Alexandru O, Sevastre AS, Castro J, Artene SA, Tache DE, Purcaru OS, Sfredel V, Tataranu LG, Dricu A. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines. Int J Mol Sci 2019;20:E4663. [PMID: 31547056 DOI: 10.3390/ijms20194663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang P, Li J, Diao Q, Lin Y, Zhang J, Li L, Yang G, Fang X, Li X, Chen Y, Zheng L, Lu G. Assessment of glioma response to radiotherapy using 3D pulsed-continuous arterial spin labeling and 3D segmented volume. Eur J Radiol 2016;85:1987-92. [PMID: 27776650 DOI: 10.1016/j.ejrad.2016.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ferrari B, Roda E, Priori EC, De Luca F, Facoetti A, Ravera M, Brandalise F, Locatelli CA, Rossi P, Bottone MG. A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma. Front Neurosci 2021;15:589906. [PMID: 33828444 DOI: 10.3389/fnins.2021.589906] [Reference Citation Analysis]
8 Beauchesne P, Quillien V, Faure G, Bernier V, Noel G, Quetin P, Gorlia T, Carnin C, Pedeux R. A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma. Int J Cancer 2016;138:1538-44. [PMID: 26501997 DOI: 10.1002/ijc.29898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Sauwen N, Acou M, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Huffel SV. Semi-automated brain tumor segmentation on multi-parametric MRI using regularized non-negative matrix factorization. BMC Med Imaging 2017;17:29. [PMID: 28472943 DOI: 10.1186/s12880-017-0198-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
10 Bou-Gharios J, Assi S, Bahmad HF, Kharroubi H, Araji T, Chalhoub RM, Ballout F, Harati H, Fares Y, Abou-Kheir W. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Pharmacol Rep. 2021;73:227-239. [PMID: 33140310 DOI: 10.1007/s43440-020-00180-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Eisenhut F, Engelhorn T, Arinrad S, Brandner S, Coras R, Putz F, Fietkau R, Doerfler A, Schmidt MA. A Comparison of Single- and Multiparametric MRI Models for Differentiation of Recurrent Glioblastoma from Treatment-Related Change. Diagnostics (Basel) 2021;11:2281. [PMID: 34943518 DOI: 10.3390/diagnostics11122281] [Reference Citation Analysis]
12 Benzakoun J, Robert C, Legrand L, Pallud J, Meder JF, Oppenheim C, Dhermain F, Edjlali M. Anatomical and functional MR imaging to define tumoral boundaries and characterize lesions in neuro-oncology. Cancer Radiother 2020;24:453-62. [PMID: 32278653 DOI: 10.1016/j.canrad.2020.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Xiong Z, Zhou C, Wang L, Zhu R, Zhong L, Wan D, Wang Q. Circular RNA SMO sponges miR-338-3p to promote the growth of glioma by enhancing the expression of SMO. Aging (Albany NY) 2019;11:12345-60. [PMID: 31895689 DOI: 10.18632/aging.102576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
14 Politko MO, Prokaeva AI, Pashkovskaya OA, Kuper KE, Zheravin AA, Kliver EE, Tsidulko AY, Aidagulova SV, Grigorieva EV. Single X-ray irradiation modulates proteoglycan expression in brain tissue: investigation using mouse model. Mol Biol Rep 2020;47:5657-63. [PMID: 32514998 DOI: 10.1007/s11033-020-05578-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Li Y, Zhang W. Quantitative evaluation of diffusion tensor imaging for clinical management of glioma. Neurosurg Rev 2020;43:881-91. [PMID: 30417213 DOI: 10.1007/s10143-018-1050-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Jiang Z, Guo Y, Miao L, Han L, Zhang W, Jiang Y. SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11 - RAD50 - NBS1 complex in glioma. The Journal of Biochemistry 2019;165:317-22. [DOI: 10.1093/jb/mvy110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Frosina G. Positron emission tomography of high-grade gliomas. J Neurooncol 2016;127:415-25. [PMID: 26897013 DOI: 10.1007/s11060-016-2077-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
18 Lupo JM, Nelson SJ. Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma. Semin Radiat Oncol 2014;24:248-58. [PMID: 25219809 DOI: 10.1016/j.semradonc.2014.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
19 Fei Q, Qian LX, Zhang YJ, Guo WJ, Bian XH, Yin L, Yan PW, Wang TT, Qian PD, Guo Z, He X. The Utility of Diffusion and Perfusion Magnetic Resonance Imaging in Target Delineation of High-Grade Gliomas. Biomed Res Int 2020;2020:8718097. [PMID: 32851090 DOI: 10.1155/2020/8718097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Grigorieva EV. Radiation Effects on Brain Extracellular Matrix. Front Oncol 2020;10:576701. [PMID: 33134175 DOI: 10.3389/fonc.2020.576701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Dupont C, Betrouni N, Reyns N, Vermandel M. On Image Segmentation Methods Applied to Glioblastoma: State of Art and New Trends. IRBM 2016;37:131-43. [DOI: 10.1016/j.irbm.2015.12.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 4.2] [Reference Citation Analysis]
22 Bolcaen J, Descamps B, Boterberg T, Vanhove C, Goethals I. PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator. J Vis Exp 2017. [PMID: 29364211 DOI: 10.3791/56601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
23 Wang B, Zhao P, Zhang Y, Ge M, Lan C, Li C, Pang Q, Xu S, Liu Y. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas. J Neurooncol 2018;139:185-93. [DOI: 10.1007/s11060-018-2859-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Özcan H, Emiroğlu BG, Sabuncuoğlu H, Özdoğan S, Soyer A, Saygı T. A comparative study for glioma classification using deep convolutional neural networks. Math Biosci Eng 2021;18:1550-72. [PMID: 33757198 DOI: 10.3934/mbe.2021080] [Reference Citation Analysis]
25 Windisch P, Röhrich M, Regnery S, Tonndorf-Martini E, Held T, Lang K, Bernhardt D, Rieken S, Giesel F, Haberkorn U, Debus J, Adeberg S. Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma. Radiother Oncol 2020;150:159-63. [PMID: 32598977 DOI: 10.1016/j.radonc.2020.06.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
26 Sengupta A, Agarwal S, Gupta PK, Ahlawat S, Patir R, Gupta RK, Singh A. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images. Eur J Radiol 2018;106:199-208. [PMID: 30150045 DOI: 10.1016/j.ejrad.2018.07.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
27 Wang H, Liu G, Li T, Wang N, Wu J, Zhi H. MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1. Arch Med Sci 2020;16:1166-75. [PMID: 32864006 DOI: 10.5114/aoms.2020.95027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 von Neubeck C, Seidlitz A, Kitzler HH, Beuthien-Baumann B, Krause M. Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs. Br J Radiol 2015;88:20150354. [PMID: 26159214 DOI: 10.1259/bjr.20150354] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
29 Wang Q, Xiao F, Qi F, Song X, Yu Y. Risk Factors for Cognitive Impairment in High-Grade Glioma Patients Treated with Postoperative Radiochemotherapy. Cancer Res Treat 2020;52:586-93. [PMID: 32019288 DOI: 10.4143/crt.2019.242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Pinel S, Thomas N, Boura C, Barberi-Heyob M. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv Drug Deliv Rev 2019;138:344-57. [PMID: 30414495 DOI: 10.1016/j.addr.2018.10.013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]
31 French Panel., North Africa Panel. Guidelines, "minimal requirements" and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working party. Crit Rev Oncol Hematol 2016;98:189-99. [PMID: 26626226 DOI: 10.1016/j.critrevonc.2015.10.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Verma A, Arora A, Bhatt AN, Arya MB, Prasad AK, Parmar VS, Dwarakanath BS. Radiosensitization of calreticulin-overexpressing human glioma cell line by the polyphenolic acetate 7, 8-diacetoxy-4-methylcoumarin. Cancer Rep (Hoboken) 2021;:e1326. [PMID: 34472223 DOI: 10.1002/cnr2.1326] [Reference Citation Analysis]
33 van de Weijer T, Broen MPG, Moonen RPM, Hoeben A, Anten M, Hovinga K, Compter I, van der Pol JAJ, Mitea C, Lodewick TM, Jacquerie A, Mottaghy FM, Wildberger JE, Postma AA. The Use of 18F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds—A Narrative Review. Diagnostics 2022;12:1202. [DOI: 10.3390/diagnostics12051202] [Reference Citation Analysis]
34 Salvatore D, Lo Dico A, Martelli C, Diceglie C, Ottobrini L. PET biomarkers and probes for treatment response assessment in glioblastoma: a work in progress. Clin Transl Imaging 2019;7:285-94. [DOI: 10.1007/s40336-019-00329-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Yan M, Liu Q. Differentiation therapy: a promising strategy for cancer treatment. Chin J Cancer 2016;35:3. [PMID: 26739838 DOI: 10.1186/s40880-015-0059-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
36 Woehrer A, Bauchet L, Barnholtz-Sloan JS. Glioblastoma survival: has it improved? Evidence from population-based studies. Curr Opin Neurol 2014;27:666-74. [PMID: 25364955 DOI: 10.1097/WCO.0000000000000144] [Cited by in Crossref: 19] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
37 Frosina G. Improving control of high‐grade glioma by ultra‐hyper‐fractionated radiotherapy. J of Neuroscience Research. [DOI: 10.1002/jnr.25030] [Reference Citation Analysis]
38 Anselmi M, Catalucci A, Felli V, Vellucci V, Di Sibio A, Gravina GL, Di Staso M, Di Cesare E, Masciocchi C. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience. Neuroradiol J 2017;30:240-52. [PMID: 28627984 DOI: 10.1177/1971400916688354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
39 Seker-polat F, Pinarbasi Degirmenci N, Solaroglu I, Bagci-onder T. Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives. Cancers 2022;14:443. [DOI: 10.3390/cancers14020443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
40 Dupont C, Vignion A, Mordon S, Reyns N, Vermandel M. Photodynamic therapy for glioblastoma: A preliminary approach for practical application of light propagation models. Lasers Surg Med 2018;50:523-34. [DOI: 10.1002/lsm.22739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Tang L, Peng T, Wang G, Wen X, Sun Y, Zhang S, Liu S, Wang L. Design, Synthesis and Preliminary Biological Evaluation of Novel Benzyl Sulfoxide 2-Indolinone Derivatives as Anticancer Agents. Molecules 2017;22:E1979. [PMID: 29144401 DOI: 10.3390/molecules22111979] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
42 Gries M, Thomas N, Daouk J, Rocchi P, Choulier L, Jubréaux J, Pierson J, Reinhard A, Jouan-Hureaux V, Chateau A, Acherar S, Frochot C, Lux F, Tillement O, Barberi-Heyob M. Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma. Int J Nanomedicine 2020;15:8739-58. [PMID: 33223826 DOI: 10.2147/IJN.S261352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Sauwen N, Acou M, Van Cauter S, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Van Huffel S. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI. Neuroimage Clin 2016;12:753-64. [PMID: 27812502 DOI: 10.1016/j.nicl.2016.09.021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
44 Blumenthal DT, Artzi M, Liberman G, Bokstein F, Aizenstein O, Ben Bashat D. Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine. AJNR Am J Neuroradiol 2017;38:908-14. [PMID: 28385884 DOI: 10.3174/ajnr.A5127] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
45 Kim M, Kotas J, Rockhill J, Phillips M. A Feasibility Study of Personalized Prescription Schemes for Glioblastoma Patients Using a Proliferation and Invasion Glioma Model. Cancers (Basel) 2017;9:E51. [PMID: 28505072 DOI: 10.3390/cancers9050051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]